LV12082A - Ierice arstnieciskas vielas kontroletai ievadisanai - Google Patents

Ierice arstnieciskas vielas kontroletai ievadisanai

Info

Publication number
LV12082A
LV12082A LV980050A LV980050A LV12082A LV 12082 A LV12082 A LV 12082A LV 980050 A LV980050 A LV 980050A LV 980050 A LV980050 A LV 980050A LV 12082 A LV12082 A LV 12082A
Authority
LV
Latvia
Prior art keywords
hydration
controlled delivery
gelatinous
medicament
polymer
Prior art date
Application number
LV980050A
Other languages
English (en)
Other versions
LV12082B (lv
Inventor
Gerald S Rork
James D Pipkin
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of LV12082A publication Critical patent/LV12082A/lv
Publication of LV12082B publication Critical patent/LV12082B/lv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrotherapy Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LVP-98-50A 1991-12-27 1998-03-12 Ierīce ārstnieciskas vielas kontrolētai ievadīšanai LV12082B (lv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81530491A 1991-12-27 1991-12-27
US90218892A 1992-07-29 1992-07-29

Publications (2)

Publication Number Publication Date
LV12082A true LV12082A (lv) 1998-07-20
LV12082B LV12082B (lv) 1998-09-20

Family

ID=27123932

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-98-50A LV12082B (lv) 1991-12-27 1998-03-12 Ierīce ārstnieciskas vielas kontrolētai ievadīšanai

Country Status (26)

Country Link
EP (1) EP0549331B1 (lv)
JP (1) JPH089534B2 (lv)
KR (1) KR100281609B1 (lv)
CN (1) CN1074368A (lv)
AT (1) ATE157001T1 (lv)
AU (1) AU660057B2 (lv)
BG (1) BG61751B1 (lv)
CA (1) CA2085871C (lv)
CZ (1) CZ284045B6 (lv)
DE (1) DE69221711T2 (lv)
DK (1) DK0549331T3 (lv)
ES (1) ES2106838T3 (lv)
FI (1) FI109451B (lv)
GR (1) GR3024885T3 (lv)
HU (1) HU219594B (lv)
IL (1) IL104189A (lv)
LV (1) LV12082B (lv)
MX (1) MX9207541A (lv)
NO (1) NO310672B1 (lv)
NZ (1) NZ245514A (lv)
PL (1) PL171110B1 (lv)
RO (1) RO112810B1 (lv)
RU (1) RU2127586C1 (lv)
SK (1) SK279964B6 (lv)
WO (1) WO1993012765A1 (lv)
YU (1) YU48762B (lv)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5582838A (en) * 1994-12-22 1996-12-10 Merck & Co., Inc. Controlled release drug suspension delivery device
US5654005A (en) * 1995-06-07 1997-08-05 Andrx Pharmaceuticals, Inc. Controlled release formulation having a preformed passageway
DE59803511D1 (de) * 1997-01-14 2002-05-02 Lohmann Therapie Syst Lts Expandierbares gastroretentives therapie-system mit kontrollierter wirkstofffreisetzung im gastrointestinaltrakt
TWI243687B (en) * 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6506397B1 (en) * 1999-02-19 2003-01-14 Curt Thies Pest controlling
AU3957400A (en) 1999-04-16 2000-11-02 Novo Nordisk A/S Dry, mouldable drug formulation
PL351948A1 (en) * 1999-06-04 2003-07-14 Alza Corp Implantable gel compositions and method of making thereof
AR030128A1 (es) * 2000-08-08 2003-08-13 Daiichi Seiyaku Co Una preparacion solida altamente absorbible
RU2165251C1 (ru) * 2000-09-06 2001-04-20 Федеральное государственное унитарное предприятие Московское производственное химико-фармацевтическое объединение им. Н.А. Семашко Твердая лекарственная форма эналаприла и способ ее получения
ATE508738T1 (de) 2001-01-12 2011-05-15 Sun Pharma Advanced Res Co Ltd System zur beabstandeten abgabe von arzneimitteln
RU2179022C1 (ru) * 2001-04-19 2002-02-10 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Фармацевтическая противоязвенная композиция и способ ее получения
WO2003055467A1 (en) * 2001-12-18 2003-07-10 Synthon B.V. Simvastatin dosage forms
US8454997B2 (en) 2001-12-18 2013-06-04 Novo Nordisk A/S Solid dose micro implant
WO2003051328A1 (en) * 2001-12-18 2003-06-26 Novo Nordisk A/S Solid dose micro implant
TWI353854B (en) * 2002-06-25 2011-12-11 Alza Corp Short duration depot formulations
AR040588A1 (es) * 2002-07-26 2005-04-13 Schering Corp Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
EP1542662A1 (en) * 2002-09-28 2005-06-22 McNEIL-PPC, INC. Immediate release dosage form comprising shell having openings therein
RU2225200C1 (ru) * 2002-12-23 2004-03-10 Общество с ограниченной ответственностью Научно-производственное предприятие "Поликом" Фармацевтический состав с противогерпесной активностью и способ лечения вирусной инфекции
US20060210633A1 (en) * 2003-04-03 2006-09-21 Sun Pharmaceutical Industries Limited Programmed drug delivery system
RU2248199C1 (ru) * 2003-06-02 2005-03-20 Открытое Акционерное Общество "Акционерное Курганское общество медицинских препаратов и изделий "Синтез" (ОАО "Синтез") Глазные капли и способ их получения
DK1765454T3 (en) 2004-07-02 2016-05-02 Mati Therapeutics Inc Device for submission of treatment medium to eye
EP2004172B1 (en) 2006-03-31 2019-03-13 Mati Therapeutics Inc. Drug delivery structures and compositions for nasolacrimal system
NZ583858A (en) 2007-09-07 2012-08-31 Quadra Logic Tech Inc Lacrimal implant detection with detection device
US9974685B2 (en) 2011-08-29 2018-05-22 Mati Therapeutics Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
ES2727203T3 (es) 2011-08-29 2019-10-14 Mati Therapeutics Inc Administración por liberación sostenida de agentes activos para tratar glaucoma e hipertensión ocular
JP7626361B2 (ja) * 2018-10-25 2025-02-07 株式会社ダイセル 1型ヘルパーt細胞増加剤、食品、及び医薬

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4391797A (en) * 1977-01-05 1983-07-05 The Children's Hospital Medical Center Systems for the controlled release of macromolecules
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
US4915954A (en) * 1987-09-03 1990-04-10 Alza Corporation Dosage form for delivering a drug at two different rates
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Dispensing devices powered by hydrogel
US5057321A (en) * 1990-06-13 1991-10-15 Alza Corporation Dosage form comprising drug and maltodextrin

Also Published As

Publication number Publication date
YU48762B (sh) 1999-11-22
FI109451B (fi) 2002-08-15
SK279964B6 (sk) 1999-06-11
YU111292A (sh) 1995-12-04
GR3024885T3 (en) 1998-01-30
LV12082B (lv) 1998-09-20
PL171110B1 (pl) 1997-03-28
EP0549331A1 (en) 1993-06-30
FI943011A0 (fi) 1994-06-22
CA2085871C (en) 2002-05-07
EP0549331B1 (en) 1997-08-20
IL104189A (en) 1996-10-31
DE69221711T2 (de) 1998-03-12
DE69221711D1 (de) 1997-09-25
HU9401913D0 (en) 1994-09-28
NO942430L (no) 1994-06-27
CN1074368A (zh) 1993-07-21
ES2106838T3 (es) 1997-11-16
AU3034892A (en) 1993-08-12
HUT70437A (en) 1995-10-30
JPH089534B2 (ja) 1996-01-31
WO1993012765A1 (en) 1993-07-08
CZ284045B6 (cs) 1998-07-15
RO112810B1 (ro) 1998-01-30
KR940703653A (ko) 1994-12-12
NO942430D0 (no) 1994-06-27
ATE157001T1 (de) 1997-09-15
BG98805A (bg) 1995-03-31
JPH05255071A (ja) 1993-10-05
CZ157094A3 (en) 1994-12-15
RU2127586C1 (ru) 1999-03-20
BG61751B1 (bg) 1998-05-29
FI943011L (fi) 1994-06-22
CA2085871A1 (en) 1993-06-28
NZ245514A (en) 1994-12-22
MX9207541A (es) 1994-06-30
RU94031474A (ru) 1997-04-20
SK76994A3 (en) 1995-05-10
DK0549331T3 (da) 1997-09-15
AU660057B2 (en) 1995-06-08
IL104189A0 (en) 1993-05-13
HU219594B (hu) 2001-05-28
KR100281609B1 (ko) 2001-02-15
NO310672B1 (no) 2001-08-13

Similar Documents

Publication Publication Date Title
LV12082A (lv) Ierice arstnieciskas vielas kontroletai ievadisanai
FI972586A7 (fi) Lääkeainesuspension säädellysti vapauttava antolaite
DK0550641T3 (da) Dispenseringsanordning indeholdende et hydrofobt medium
MY103909A (en) Hydrophilic polymers for incorporating deodorants in absorbent structure
DE59505047D1 (de) Versprühbare filmbildende wirkstoffabgabesysteme zur anwendung an pflanzen
GB2238243B (en) Delayed release formulations
CA2222359A1 (fr) Composition cosmetique comprenant l'association d'un polymere filmogene et d'une dispersion de cire et utilisation de ladite association
EP0700284A4 (en) CONTROLLED-RELEASE OXYBUTYNIN FORMULATIONS
AU7719087A (en) Wound dressing, its preparation and use
DK0954245T3 (da) Ultralydsafgivelsessystem til terapeutisk anvendelse
AU7267191A (en) Method for coating active principles with a ph-sensitive polymer
DE59607949D1 (de) Feste arzneimittelform mit polymerem material verteiltem wirkstoff
CA2020590A1 (en) Solid pharmaceutical composition containing a core and an outer layer
CA2206211A1 (en) A controlled release drug suspension delivery device